EMI Planning: Car Loan of ₹10 Lakh: 5 Yrs vs 7 Yrs – What’s Better for Your Budget?

Planning to buy a car and considering a loan of ₹10 lakh? One of the key decisions you’ll need to make is choosing the loan tenure.  

A common dilemma for borrowers is whether to opt for a shorter tenure like 5 years or go for a longer one, such as 7 years. Let’s break down how your monthly budget will be impacted by each choice, assuming a fixed interest rate of 12% per annum. 

EMI Comparison: 5 Years vs 7 Years 

For example, for a loan amount of ₹10 lakh at a 12% annual interest rate: 

For a 5-year loan tenure (60 months) on ₹10 lakh at 12% interest, the approximate EMI would be ₹22,244. Over the entire loan period, you would repay a total of ₹1,334,667, which includes ₹3,34,667 as the interest paid to the lender. 

In comparison, for a 7-year tenure (84 months), the EMI drops to approximately ₹17,653. However, the total repayment increases to ₹14,82,830, with the total interest paid being ₹4,82,830. While the monthly burden is lower, the extended tenure results in a higher total interest payout. 

As you can see, the 5-year tenure comes with higher monthly EMIs but saves you nearly ₹1.5 lakh in interest. Meanwhile, the 7-year loan gives you lower EMIs but results in a significantly higher interest payout over the full term. 

You can use the EMI Calculator to calculate the EMI for different figures and understand which can fit into your monthly budget.  

Which Option Fits Your Budget? 

Your decision should depend on your monthly income, existing financial obligations, and lifestyle needs. 

Can choose 5 Years If: 

  • You have a stable income and fewer financial liabilities. 
  • You want to pay off your loan faster and save on interest. 
  • You’re comfortable with slightly higher EMIs in exchange for long-term savings.

Can choose 7 Years If: 

  • You want lower EMIs to keep your monthly budget light. 
  • You’re expecting your income to grow over time. 
  • You want to maintain liquidity for emergencies or investments. 

Impact on Financial Planning 

Shorter tenure means faster repayment and better credit profile in the long run. Lenders often see quick loan closures as a sign of creditworthiness. Additionally, repaying your loan faster frees up your future income for other financial goals such as investing, saving for a home, or even taking a vacation. 

Longer tenure, on the other hand, offers more breathing room and flexibility in managing monthly cash flow.  

Also Read: Can You Buy a Motorcycle with a Credit Card?

Conclusion  

There’s no one-size-fits-all answer. A 5-year loan helps you save more on interest and become debt-free faster, while a 7-year term offers lower monthly strain. Use an EMI calculator to assess your repayment capacity and think long term. Whichever you choose, ensure it aligns with your financial comfort and goals. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

What Does the Adani Group Do? – Main Operations, Businesses & More

The Adani Group is one of India’s largest multinational conglomerates, known for its diverse business operations and rapid expansion across key sectors of the Indian economy.  

Founded in 1988 by Gautam Adani, the group initially began as a commodity trading firm but has since evolved into a powerhouse with interests in infrastructure, energy, logistics, resources, agribusiness, real estate, defence, and aerospace. 

Core Areas of Business 

  • Energy and Utilities 

Adani is one of the largest private power producers in India. Its energy arm, Adani Power, is engaged in thermal power generation with power plants in several Indian states.  

The company has also made a strong push into renewable energy through Adani Green Energy Limited, which operates solar and wind power projects.  

Adani Energy Solutions Ltd (previously known as Adani Transmission), another group entity, manages the transmission of electricity across India, while Adani Total Gas focuses on city gas distribution. 

  • Ports and Logistics 

The group operates India’s largest private port network through Adani Ports and Special Economic Zone (APSEZ). Its flagship, Mundra Port in Gujarat, is one of the largest commercial ports in India. The company is also involved in logistics, with an integrated presence in inland logistics, warehousing, and transportation. 

  • Mining and Resources 

Adani Enterprises Limited (AEL), incorporated in 1993, is the flagship entity of the Adani Group and serves as the incubator for the Group’s emerging businesses. Several key companies: Adani Power Ltd, Adani Transmission Ltd, Adani Ports and Special Economic Zone Ltd, Adani Gas Ltd, Adani Green Energy Ltd, and Adani Wilmar Ltd, were initially nurtured under AEL before evolving into independently listed entities. 

AEL has a diversified business portfolio. On a standalone basis, its primary revenue streams come from Integrated Resource Management (IRM) and Mining Services. However, on a consolidated level, major contributions to revenue and profitability come from segments such as integrated solar PV cell and module manufacturing and airport operations.  

Other areas like shipping, bunkering, and agri-storage also support AEL’s overall financial performance, though they contribute on a relatively smaller scale. 

  • Airports 

Adani Group has entered the airport business and currently manages seven airports in India, including Mumbai, Ahmedabad, Lucknow, Mangalore, Jaipur, Thiruvananthapuram, and Guwahati. Through Adani Airports Holdings Ltd, the group aims to develop world-class aviation infrastructure. 

  • Food and Agri-business 

Under Adani Wilmar Limited, the group manufactures and markets Fortune brand edible oils, pulses, rice, wheat flour, and other packaged food products. It is one of India’s leading FMCG companies and has a vast distribution network across urban and rural India. 

  • Real Estate, Defence, and Aerospace 

Adani Realty focuses on developing residential and commercial real estate projects. Meanwhile, the group has also ventured into defence manufacturing and aerospace technologies, partnering with international firms to strengthen India’s self-reliance in these sectors. 

Read: What Does Adani Enterprises Do? An Overview!

Sustainability and Innovation 

The Adani Group is increasingly focusing on sustainability, investing heavily in green hydrogen, solar energy, and climate-conscious infrastructure. The group has committed billions of dollars toward building one of the world’s largest green energy ecosystems. 

Global Presence and Vision 

Adani Group has expanded its global footprint in countries such as Australia, Indonesia, Sri Lanka, and Bangladesh. With a vision of “Nation Building,” the group aligns its growth with India’s infrastructure and economic goals, playing a vital role in logistics, energy access, and industrial development. 

Conclusion  

The Adani Group is a highly diversified conglomerate that is driving transformation across India’s economic landscape. Its focus on infrastructure, energy, and innovation positions it as a central player in India’s growth story. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Orient Cement FY25 Profit Down YoY; Declares ₹0.50 Dividend

Orient Cement announced its audited financial results for the quarter and year ended March 31, 2025

Revenue Performance 

In Q4 FY25, the company recorded a total income of ₹83,284.11 lakh, registering a sequential rise from ₹64,586.58 lakh in the previous quarter. However, on a year-over-year basis, the income was lower than ₹89,553.76 lakh reported in Q4 FY24. Revenue from operations for the March 2025 quarter stood at ₹82,518.78 lakh. 

For the full year FY25, total income came in at ₹2,72,869.72 lakh, while revenue from operations was ₹2,70,883.37 lakh, as compared to ₹3,20,060.94 lakh and ₹3,18,508.98 lakh, respectively, in FY24, indicating a decline over the previous year. 

Profitability Trends 

Net profit in Q4 FY25 stood at ₹4,207.00 lakh, showing an improvement from ₹1,014.11 lakh in Q3 FY25. However, the figure was considerably lower than ₹6,819.98 lakh earned in the same quarter last year, pointing to profitability pressure on a YoY basis.  

For the full financial year, the company reported a net profit of ₹9,124.64 lakh, down from ₹17,485.27 lakh in FY24. 

Dividend Announcement 

The Board of Directors has recommended a dividend of ₹0.50 per equity share of ₹1 each (50%) for FY25. The company stated that this dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM). If approved, the dividend will be paid/dispatched within 30 days from the date of declaration. 

Also Read: EMI Planning: What Should Be Your EMI If You Earn ₹50,000 Per Month?

Orient Cement Share Price Performance 

On April 15, 2025, Orient Cement share price opened at ₹352.10, up from its previous close of ₹357.80. At 1:07 PM, the share price of Orient Cement was trading at ₹358.50, up by 0.20 % on the NSE. 

Conclusion 

While Orient Cement delivered sequential growth in revenue and quarterly profit recovery, its annual performance showed a downward trend, both in income and profit. The proposed dividend signals management’s confidence despite a challenging year. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Sensex Soars 1,500+ Points on April 15, IndusInd Bank Leads Rally

Indian benchmark indices opened positively on Tuesday. At 10:58 AM, BSE Sensex rose over 1556.62 points after the market opened and was trading at 76,713.88. Sensex opened at 76,852.06 and was trading at 76,713.88, up by 2.07%.  

BSE Sensex 30 Stocks 

As of 10:59 AM, out of the 30 stocks in the BSE Sensex, only 3 were trading in the red, while the remaining stocks were witnessing a rise. Among the gainers, IndusInd Bank stood out with a upward momentum, registering a notable gain of ~6.52% on the BSE.  

Other stocks on the green were, Adani Ports, Tata Motors and LT, which rose by 4.98%, 4.61% and 4.49%, respectively.  

On the other hand, Nestle India, ITC and Hindustan Unilever trading in the red. These stocks saw a decline of over 0.15% each.  

Sectoral Performance  

All the sectoral indices on BSE were in green. BSE Bankex and BSE Sensex 50 rose by 2.31% and 1.99%, respectively. 

Conclusion  

The rally in Sensex reflects market sentiment, driven by gains in banking and auto stocks. Investors remain optimistic across sectors. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Gensol Engineering Share Price Dips 2.08% on April 15; Declares 1:10 Stock Split

Gensol Engineering has been in focus on Tuesday. The company has announced a stock split in the ratio of 1:10, bringing the face value of its equity shares down from ₹10 to ₹1 per share.  

The announcement came following the revised proceedings of its Extraordinary General Meeting (EGM), held on April 12, 2025. During the meeting, the Chairman presented the resolution regarding the stock split for shareholder approval.  

Preferential Allotment to Promoter Group Proposed 

In addition to the stock split, Gensol also proposed a special resolution concerning the issue of securities on a preferential basis to certain members of the promoter group. While the stock split falls under the category of an ordinary resolution, the preferential allotment requires special resolution approval.  

The company has stated that the final results of the voting on both resolutions are still pending and will be declared after receiving the report from the appointed Scrutinizer. 

Share Price Movement  

Gensol Engineering’s stock has been under considerable pressure in recent weeks. Once trading around ₹796.40 in early January 2025, the share has declined sharply to ₹126.02 on the NSE, on April 15.  

On April 15, 2025, Gensol Engineering share price (NSE: GENSOL) opened at ₹126.02, down from its previous close of ₹132.66. At 10:24 AM, the share price of Gensol Engineering was trading at ₹129.90, down by 2.08% on the NSE. 

Commissions Solar Power Plant in Jharkhand 

Meanwhile, recently, Gensol Engineering Limited has successfully commissioned a ground-mounted solar power plant in Panchet, Dhanbad district, Jharkhand, under a ₹40 crore EPC contract. Spread across 40 acres, the plant will generate over 15 million units of clean energy annually and includes five years of operations and maintenance (O&M) support.  

Despite challenging terrain marked by loose soil, rocks, and mining zones, Gensol used advanced Mounting Structure Systems and high-efficiency PV modules to ensure optimal performance. The project is expected to offset 21,000 metric tonnes of CO₂ emissions annually, reinforcing Jharkhand’s commitment to renewable energy and sustainability. 

Read: What Does Adani Enterprises Do?

Conclusion 

The stock split and preferential issue could be key steps in Gensol Engineering’s strategic repositioning. Investors now await the outcome of the voting process to gauge future direction. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Biocon to Launch Interchangeable Biosimilar Yesafili™ in U.S. by 2026

Biocon Biologics Ltd (BBL), a global biosimilars company and subsidiary of Biocon Ltd, has entered into a settlement and license agreement with Regeneron that facilitates the U.S. commercialisation of Yesafili™ (aflibercept-jbvf), an interchangeable biosimilar of Eylea® (aflibercept).  

As part of this agreement, both parties will dismiss pending legal proceedings in the U.S., including an appeal before the United States Court of Appeals for the Federal Circuit and litigation in the U.S. District Court for the Northern District of West Virginia.  

The settlement enables Biocon Biologics to launch Yesafili in the U.S. by the second half of 2026, or earlier under specific conditions. The detailed terms of the settlement remain confidential. 

FDA Approval and Canadian Settlement Already in Place 

Yesafili received approval from the U.S. Food and Drug Administration (FDA) in May 2024 as an interchangeable biosimilar, granting it the potential to be substituted for its reference product, Eylea®, without the need for physician intervention.  

Additionally, Biocon Biologics had earlier reached a settlement agreement with Bayer Inc. and Regeneron Pharmaceuticals, Inc. in Canada, allowing for the launch of Yesafili in the Canadian market no later than July 1, 2025. 

Therapeutic Use and Efficacy 

Yesafili is used in the treatment of several ophthalmic conditions, including neovascular (wet) age-related macular degeneration (AMD), macular oedema due to retinal vein occlusion (RVO), diabetic macular oedema (DME), and myopic choroidal neovascularisation (myopic CNV).  

As a vascular endothelial growth factor (VEGF) inhibitor, it helps prevent abnormal blood vessel growth in the retina. Studies have demonstrated that Yesafili is highly similar in quality, safety, and efficacy to its reference product, Eylea. 

Read: What Should Be Your EMI If You Earn ₹50,000 Per Month?

Interchangeability Advantage 

Yesafili holds interchangeable status in the U.S., a designation granted to biosimilars that meet additional requirements for substitution. It assures prescribers and patients that Yesafili can deliver the same clinical results as Eylea and can be safely alternated without increased risk. 

Commenting on this, the CEO & Managing Director of Biocon Biologics Ltd, Shreehas Tambe, said, “This settlement clears the path for Biocon Biologics to be among the first to bring a reliable, high-quality aflibercept biosimilar to patients and healthcare providers in the United States. As the first-to-file interchangeable biosimilar to Eylea®, YESAFILI affirms our scientific strength and marks our strategic entry into Ophthalmology, expanding our footprint in the U.S. and advancing our mission to increase access to life-changing treatments.” 

Conclusion 

With strategic settlements in the U.S. and Canada, and regulatory approvals in place, Biocon Biologics is well-positioned to strengthen its presence in the global ophthalmology biosimilars market through the commercialization of Yesafili. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Ahluwalia Contracts Bags ₹396.5 Crore Project from Godrej Properties

Ahluwalia Contracts (India) Limited, a leading name in the construction and engineering sector, has announced a major contract win from Godrej Properties Ltd. The contract pertains to core construction work at the Godrej Riverine residential project, located in Sector-44, Noida, Uttar Pradesh. 

Scope of Work and Project Details 

The order involves Core and Shell Works of both the substructure and superstructure for all four residential towers (T1, T2, T3, and T4).  

Additionally, it includes construction-related components such as the NTA, club facilities, retail areas, boundary wall, rainwater harvesting (RWH) systems, waterproofing, and lightning protection systems (LPS). This comprehensive scope highlights Ahluwalia Contracts’ capabilities in executing complex and large-scale residential developments. 

Also Read: EMI Planning: What Should Be Your EMI If You Earn ₹50,000 Per Month?

Domestic Housing Project to be Completed in 25 Months 

The order is a domestic contract, reinforcing Ahluwalia Contracts’ strong presence in the Indian real estate construction space. The total contract value is pegged at ₹396.50 crore (excluding GST), making it a significant addition to the company’s project pipeline. The project is expected to be executed and completed within a period of 25 months. 

Ahluwalia Contracts (India) Share Price 

On April 15, 2025, Ahluwalia Contracts share price opened at ₹927.60, up from its previous close of ₹862.55. At 9:35 AM, the share price of Ahluwalia Contracts was trading at ₹917.00, up by 6.31 % on the NSE. 

Conclusion 

This contract win marks another milestone for Ahluwalia Contracts as it continues to strengthen its portfolio in the housing and real estate construction sector. The partnership with Godrej Properties, a trusted name in real estate, also adds to the company’s credibility and visibility in high-end residential development. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

India’s Auto Parts Market Set to Hit $145 Billion by 2030: NITI Aayog

NITI Aayog, India’s premier policy think tank, has unveiled a vision for the country’s automotive sector through its latest report titled “Automotive Industry: Powering India’s Participation in Global Value Chains.”  

The report projects that India’s automotive component production could grow to USD 145 billion by 2030. Alongside this, the export potential is expected to triple from the current USD 20 billion to USD 60 billion, paving the way for India to emerge as a key player in the global automotive manufacturing landscape. 

Strategic Interventions to Drive Growth 

To turn this vision into reality, the report outlines a series of strategic fiscal and non-fiscal interventions. These strategies are aligned across four categories of components: Emerging and Complex, Conventional and Complex, Conventional and Simple, and Emerging and Simple, based on their complexity and level of manufacturing maturity.  

On the fiscal front, NITI Aayog highlights the importance of providing operational expenditure support and facilitating investment in research and development. It also recommends encouraging IP development, strengthening skill training programs, and focusing on the creation of manufacturing clusters. 

Non-fiscal measures include the adoption of Industry 4.0 technologies, fostering international partnerships, and simplifying regulatory procedures. The report also emphasizes the need for more flexible labor laws and improved mechanisms for supplier discovery to enhance competitiveness across the value chain. 

India’s Global Standing and Challenges 

India is currently the fourth-largest vehicle producer in the world, trailing only behind China, the United States, and Japan. It manufactures nearly six million vehicles annually and has gained a robust presence in both domestic and export markets, especially in the small car and utility vehicle segments.

However, despite this scale, India’s share in the global automotive components trade remains modest at around 3 percent. Most of the global trade is concentrated in high-value areas like engine parts, transmission systems, and steering systems—sectors where India’s presence is still limited, with a share of just 2 to 4 percent. 

The report identifies key challenges such as high operational costs, infrastructural limitations, low R&D spending, and only moderate integration into global value chains. These factors continue to hamper India’s efforts to scale up in precision manufacturing. 

Also Read: EMI Planning: What Should Be Your EMI If You Earn ₹50,000 Per Month?

Conclusion 

With strong policy support, targeted investments, and structural reforms, India can significantly enhance its share in the global automotive component market. NITI Aayog’s vision provides a clear pathway to transform India into a leading exporter and a global manufacturing powerhouse in the automotive sector by 2030. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Hexaware Technologies Interim Dividend of ₹5.75 Record Date Today, April 15, 2025

Hexaware Technologies Limited’s Board of Directors has declared and approved an interim dividend of ₹5.75 per equity share.  

On April 11, 2025, Hexaware Technologies share price (NSE: HEXT) opened at ₹664.00 and closed at ₹630.55, down by 0.59%. The stock price touched its day’s low at ₹630.00.  

Hexaware Technologies Interim Dividend Record Date 

The Board of Directors, at its meeting held on April 4, 2025, declared the first interim dividend of ₹5.75 per equity share (575%) of face value ₹1 each for the financial year 2025.   

The company has fixed April 15, 2025, as the record date for determining the eligibility of shareholders for the interim dividend. The dividend will be paid to all eligible shareholders whose names appear in the Register of Members and/or Depositories as of the record date. They stated that the payment will be made on April 23, 2025. 

Latest Financial Highlights 

For Q4CY24, the company reported revenue of USD 372 million (₹31,544 million), marking a 0.5% QoQ decline in USD terms but an 18.5% YoY growth. In INR terms, revenue rose 0.6% QoQ and 20.6% YoY, while in constant currency, it grew 0.2% QoQ and 18.8% YoY.  

For the full year CY24, revenue stood at USD 1,429 million (₹1,19,744 million), reflecting a 13.7% YoY increase in USD terms and 15.4% in INR terms, with constant currency growth at 13.5% YoY.  

EBITDA margin for Q4CY24 stood at 16.3%, with a 2.3% QoQ and 50.7% YoY rise in absolute terms, and an improvement of 28 bps QoQ and 326 bps YoY. For CY24, EBITDA margin was 15.9%, up 19.8% YoY in absolute terms and 59 bps in percentage terms. 

Also Check: Top 10 Blue Chip Stocks in India in April 2025!

About Hexaware Technologies Ltd 

Hexaware Technologies Ltd was incorporated in 1992. The company offers AI based digital & technology solutions. 

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Stocks To Watch Today on April 15, 2025: Reliance Industries, Dr.Reddy’s, Sula Vineyards & More in Focus

On Tuesday, April 15, 2025, the Indian benchmark indices Sensex and Nifty 50 are expected to open on a positive note, tracking a rally in global markets. Check out a few stocks that might be in focus during the trading session. 

Reliance Industries 

Nauyaan Tradings, a step-down wholly owned subsidiary of Reliance Industries, has acquired an additional 10% equity stake in Nauyaan Shipyard from Welspun Corp for ₹51.72 crore. Nauyaan Shipyard remains a step-down subsidiary of Reliance Industries. 

Tata Power 

Tata Power Renewable Energy, a subsidiary of Tata Power, has entered into a power purchase agreement (PPA) with NTPC to establish a 200 MW Firm and Dispatchable Renewable Energy Project. The project, valued at around ₹4,500 crore, is expected to be completed within 24 months. 

Sula Vineyards 

Sula Vineyards reported record-high revenue of ₹618.8 crore in FY25, marking a 1.7% increase from ₹608.7 crore in the previous fiscal year. In Q4 FY25, the company posted revenue of ₹132.6 crore, up 0.7% year-on-year. 

Ashoka Buildcon 

Ashoka Buildcon has emerged as the lowest bidder for a ₹568.86 crore gauge conversion project by Central Railway. The work covers earthwork, bridges, RUBs, P-way, and civil construction over a 53.3 km stretch between Pachora and Jamner. Completion is expected within 30 months. 

Zydus Lifesciences 

Zydus Lifesciences has received final approval from the US FDA to manufacture Jaythari (Deflazacort) Tablets in 6 mg, 18 mg, 30 mg, and 36 mg strengths. The medication is used in treating Duchenne muscular dystrophy (DMD) in patients aged 5 years and above 

Dr. Reddy’s Laboratories 

Dr. Reddy’s Laboratories has dismissed reports suggesting a 25% workforce reduction. It stated that the claims made in a recent news article are unfounded and confirmed that operations are continuing as usual. 

Conclusion 

Apart from these, several other stocks may remain in focus throughout the day due to market trends and company-specific developments. Keep an eye on key updates and market movements. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.